Academic Founder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A new spin-out company from the University of Sheffield is set to pioneer novel therapies for rare genetic neurological diseases.  BlackfinBio has raised £2.75 million seed investment to advance revolutionary treatments for Hereditary Spastic Paraple

Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics Study conducted by Nucleome's academic founders at the University

Investegate announcements from Nucleome Therapeutics, Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics